DK3730136T3 - Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom - Google Patents

Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom Download PDF

Info

Publication number
DK3730136T3
DK3730136T3 DK20163104.1T DK20163104T DK3730136T3 DK 3730136 T3 DK3730136 T3 DK 3730136T3 DK 20163104 T DK20163104 T DK 20163104T DK 3730136 T3 DK3730136 T3 DK 3730136T3
Authority
DK
Denmark
Prior art keywords
ferricitrate
patients
treatment
kidney disease
chronic kidney
Prior art date
Application number
DK20163104.1T
Other languages
English (en)
Inventor
Enrique Poradosu
Ron Bentsur
Iii James F Oliviero
Original Assignee
Keryx Biopharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Keryx Biopharmaceuticals Inc filed Critical Keryx Biopharmaceuticals Inc
Application granted granted Critical
Publication of DK3730136T3 publication Critical patent/DK3730136T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/295—Iron group metal compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
DK20163104.1T 2012-06-21 2013-06-21 Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom DK3730136T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261662565P 2012-06-21 2012-06-21
US201361757229P 2013-01-28 2013-01-28
US201361801050P 2013-03-15 2013-03-15
US201361800618P 2013-03-15 2013-03-15
EP13807102.2A EP2863906B1 (en) 2012-06-21 2013-06-21 Use of ferric citrate in the treatment of chronic kidney disease patients

Publications (1)

Publication Number Publication Date
DK3730136T3 true DK3730136T3 (da) 2024-01-22

Family

ID=49769729

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20163104.1T DK3730136T3 (da) 2012-06-21 2013-06-21 Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom

Country Status (17)

Country Link
US (3) US20130345303A1 (da)
EP (3) EP3730136B1 (da)
JP (4) JP2015535209A (da)
KR (2) KR102150135B1 (da)
CN (2) CN113244209A (da)
AU (2) AU2013278000A1 (da)
BR (1) BR112014032049A2 (da)
CA (1) CA2876982A1 (da)
DK (1) DK3730136T3 (da)
EA (1) EA201590062A1 (da)
ES (1) ES2796254T3 (da)
HK (2) HK1210013A1 (da)
IL (1) IL236356A0 (da)
MX (1) MX2014015615A (da)
PL (1) PL3730136T3 (da)
SG (2) SG10201805177PA (da)
WO (1) WO2013192565A2 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2563819C2 (ru) 2009-07-21 2015-09-20 Керикс Байофармасьютикалз, Инк. Лекарственные формы цитрата железа (iii)
TWI653043B (zh) * 2012-12-20 2019-03-11 瑞士商伊蘭科動物健康公司 新用途
WO2014197725A1 (en) 2013-06-05 2014-12-11 Tricida, Inc. Proton-binding polymers for oral administration
EP2856941B1 (en) * 2013-10-01 2020-11-25 Fresenius Medical Care Deutschland GmbH Method and apparatuses for determining a patient's daily loss of iron
SG11201603091QA (en) * 2013-11-04 2016-05-30 Keryx Biopharmaceuticals Inc Ferric citrate for reducing cardiac failure in chronic kidney disease patients
WO2015110968A1 (en) * 2014-01-23 2015-07-30 Lupin Limited Pharmaceutical grade ferric citrate and method for its production
WO2015198304A1 (en) 2014-06-22 2015-12-30 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
MA41150B1 (fr) 2014-12-10 2020-06-30 Tricida Inc Polymères de liaison aux protons pour administration orale
CA2978073A1 (en) * 2015-03-04 2016-09-09 Keryx Biopharmaceuticals, Inc. Use of ferric citrate in the treatment of iron-deficiency anemia
CN104688706B (zh) * 2015-04-01 2017-07-14 成都欣捷高新技术开发有限公司 一种高载药量、快速溶出的枸橼酸铁组合物及其制备方法
WO2016162794A1 (en) * 2015-04-08 2016-10-13 Leiutis Pharmaceuticals Pvt Ltd Pharmaceutical compositions of ferric citrate
WO2016162888A1 (en) * 2015-04-09 2016-10-13 Actavis Group Ptc Ehf. Process for preparing pharmaceutical grade ferric citrate
MA44875A (fr) 2016-05-06 2019-03-13 Tricida Inc Compositions pour le traitement de troubles acido-basiques
EP3685831A4 (en) 2017-09-19 2021-06-16 Japan Tobacco Inc. USE OF FERRIC CITRATE IN THE PREVENTION AND / OR TREATMENT OF FERRIPRIVE ANEMIA IN A PATIENT WITH HYPERMENORRHEA AND / OR A PATIENT WITH A GYNECOLOGICAL DISEASE ASSOCIATED WITH HYPERMENORRHEA
AU2018360867A1 (en) 2017-11-03 2020-04-30 Tricida, Inc. Compositions for and method of treating acid-base disorders
WO2019236639A1 (en) * 2018-06-04 2019-12-12 Tricida, Inc. Method of treating acid-base disorders
WO2020089227A1 (en) 2018-10-29 2020-05-07 Pharmacosmos Holding A/S Treating iron deficiency with ferric carboxymaltose
WO2022150623A1 (en) 2021-01-08 2022-07-14 Akebia Therapeutics, Inc. Compounds and composition for the treatment of anemia
TW202313072A (zh) 2021-05-27 2023-04-01 美商凱立克斯生物製藥股份有限公司 檸檬酸鐵之兒科調配物
CN115024495B (zh) * 2022-06-27 2024-03-22 北京金康普食品科技有限公司 改善肾病患者钙磷代谢的营养组合物及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2261750A1 (en) * 1996-07-19 1998-01-29 Nikken Chemicals Co., Ltd. Remedies for hyperphosphatemia
US5753706A (en) * 1996-12-16 1998-05-19 Hsu; Chen Hsing Methods for treating renal failure
TWI335218B (en) 2003-02-19 2011-01-01 Panion & Bf Biotech Inc Ferric organic compounds, uses thereof and methods of making same
US8093423B2 (en) 2003-02-19 2012-01-10 Globoasia, Llc Pharmaceutical-grade ferric organic compounds, uses thereof and method of making same
CN1600302A (zh) * 2003-09-22 2005-03-30 宝龄富锦生技股份有限公司 含有柠檬酸铁的医药组合物以及药用级柠檬酸铁及其制法和含有药用级柠檬酸铁的膳食营养品
US20060134227A1 (en) * 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
CA3050453C (en) 2005-08-18 2021-07-27 Panion & Bf Biotech Inc. Pharmaceutical-grade ferric organic compounds, uses thereof and methods of making same
PT1973549T (pt) * 2006-01-06 2016-10-25 Luitpold Pharm Inc Métodos e composições para administração de ferro
ES2580127T3 (es) * 2006-01-30 2016-08-19 Panion & Bf Biotech Inc. Procedimiento de tratamiento de la nefropatía crónica
RU2563819C2 (ru) 2009-07-21 2015-09-20 Керикс Байофармасьютикалз, Инк. Лекарственные формы цитрата железа (iii)

Also Published As

Publication number Publication date
PL3730136T3 (pl) 2024-03-25
KR20150036131A (ko) 2015-04-07
AU2018203205A1 (en) 2018-05-31
EP2863906A2 (en) 2015-04-29
US20130345303A1 (en) 2013-12-26
ES2796254T3 (es) 2020-11-26
CN104884055A (zh) 2015-09-02
MX2014015615A (es) 2015-03-20
CN113244209A (zh) 2021-08-13
KR20200103855A (ko) 2020-09-02
WO2013192565A2 (en) 2013-12-27
SG10201805177PA (en) 2018-07-30
JP2020100638A (ja) 2020-07-02
BR112014032049A2 (pt) 2017-07-25
EP2863906B1 (en) 2020-03-18
IL236356A0 (en) 2015-02-26
US20150079168A1 (en) 2015-03-19
AU2018203205B2 (en) 2020-03-12
WO2013192565A3 (en) 2015-10-15
JP2015535209A (ja) 2015-12-10
HK1214503A1 (zh) 2016-07-29
KR102150135B1 (ko) 2020-08-31
CA2876982A1 (en) 2013-12-27
EA201590062A1 (ru) 2016-02-29
JP2022070945A (ja) 2022-05-13
EP3730136A1 (en) 2020-10-28
US20140234416A1 (en) 2014-08-21
HK1210013A1 (en) 2016-04-15
SG11201408521WA (en) 2015-01-29
EP4335436A2 (en) 2024-03-13
EP3730136B1 (en) 2023-12-27
AU2013278000A1 (en) 2015-01-22
JP2018138562A (ja) 2018-09-06
EP4335436A3 (en) 2024-05-15

Similar Documents

Publication Publication Date Title
DK3730136T3 (da) Anvendelse af ferricitrat til behandlingen af patienter med kronisk nyresygdom
IL285843A (en) Ibrutinib for use in the treatment of graft-versus-host disease
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
GB2533508B (en) Patient support usable with bariatric patients
DK3811943T3 (da) Forbindelse til anvendelse til behandling af øjenlidelser
DK3329909T3 (da) Fenfluramin til anvendelse i behandling af dravet syndrom
DK2734126T3 (da) Medicinske anordninger med aftagelige drejelige kæber
DK3329951T3 (da) Intravaskulær blodpumpe
DK2844279T3 (da) Doseringsprogrammer til behandling af pompes sygdom
DK2838539T3 (da) Østrogenderivater til anvendelse i behandlingen af neurologiske forstyrrelser
DK2827813T3 (da) Kuldebehandlingsindretning
DK3040336T3 (da) Forbindelser til brug i behandling af TYK2 Kinase-medierede tilstande
DK3086793T3 (da) Anvendelse af oxygenerede cholesterolsulfater (ocs) til behandling af nyredysfunktion
DK3400943T3 (da) Forbindelser til anvendelse til behandling af hjernemetastaser hos en patient med erbb2+ brystkræft
DK2984184T3 (da) Anvendelse af dnq eller dnq-87 i kombination med en parp1-inhibitor til behandlingen af cancer
HK1212255A1 (en) Artemisinin and its derivatives for use in the treatment of kidney disease
DK2688588T3 (da) Hurtig- og langtidsvirkende immunologisk terapeutisk middel
DK3363437T3 (da) Aminoindanforbindelser og anvendelse deraf i behandling af smerte
FR3000491B1 (fr) Composes utilisables dans le traitement des infections mycobacteriennes
NO20120892A1 (no) Truge med integrert ledd
SG11201601490XA (en) Risk markers for cardiovascular disease in patients with chronic kidney disease
ITRM20120530A1 (it) Compounds for use in the treatment of parasitic diseases
DK2869845T3 (da) Dimert protein med tredobbelte mutationer
BR112014010432A2 (pt) uso médico
DK2694056T3 (da) Terapeutisk behandling